Dimensional Fund Advisors’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.44M | Sell |
1,372,637
-34,412
| -2% | -$237K | ﹤0.01% | 2303 |
|
|
2025
Q1 | $4.05M | Sell |
1,407,049
-11,641
| -0.8% | -$33.5K | ﹤0.01% | 2556 |
|
|
2024
Q4 | $6.67M | Sell |
1,418,690
-4,805
| -0.3% | -$22.6K | ﹤0.01% | 2454 |
|
|
2024
Q3 | $5.08M | Sell |
1,423,495
-57,431
| -4% | -$205K | ﹤0.01% | 2515 |
|
|
2024
Q2 | $9.18M | Buy |
1,480,926
+176,114
| +13% | +$1.09M | ﹤0.01% | 2302 |
|
|
2024
Q1 | $12.3M | Buy |
1,304,812
+329,533
| +34% | +$3.11M | ﹤0.01% | 2215 |
|
|
2023
Q4 | $6.58M | Buy |
975,279
+413,281
| +74% | +$2.79M | ﹤0.01% | 2478 |
|
|
2023
Q3 | $2.5M | Buy |
561,998
+86,663
| +18% | +$385K | ﹤0.01% | 2712 |
|
|
2023
Q2 | $1.57M | Sell |
475,335
-279,551
| -37% | -$922K | ﹤0.01% | 2841 |
|
|
2023
Q1 | $2.15M | Buy |
754,886
+368,054
| +95% | +$1.05M | ﹤0.01% | 2730 |
|
|
2022
Q4 | $2.82K | Buy |
386,832
+152,752
| +65% | +$1.11K | ﹤0.01% | 2624 |
|
|
2022
Q3 | $1.89M | Sell |
234,080
-128,024
| -35% | -$1.04M | ﹤0.01% | 2723 |
|
|
2022
Q2 | $1.77M | Buy |
362,104
+79,311
| +28% | +$388K | ﹤0.01% | 2776 |
|
|
2022
Q1 | $6.69M | Buy |
282,793
+95,272
| +51% | +$2.25M | ﹤0.01% | 2448 |
|
|
2021
Q4 | $3.32M | Buy |
187,521
+136,773
| +270% | +$2.42M | ﹤0.01% | 2699 |
|
|
2021
Q3 | $1.43M | Sell |
50,748
-24,835
| -33% | -$701K | ﹤0.01% | 2947 |
|
|
2021
Q2 | $792K | Buy |
75,583
+25,768
| +52% | +$270K | ﹤0.01% | 3080 |
|
|
2021
Q1 | $587K | Buy |
+49,815
| New | +$587K | ﹤0.01% | 3114 |
|